Jazz Pharmaceuticals (JAZZ) Asset Utilization Ratio (2011 - 2026)

Jazz Pharmaceuticals' Asset Utilization Ratio history runs 16 years deep, the most recent figure standing at 0.38 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio rose 9.33% year-over-year to 0.38; the TTM figure through Mar 2026 stood at 0.38 (up 9.33% YoY), while the FY2025 annual figure was 0.36, up 3.7% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.38, up from 0.37 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.38 in Q1 2026, with the low at 0.27 in Q1 2022.
• The 5-year median for Asset Utilization Ratio is 0.34 (2023), against an average of 0.34.
• Peak annual rise in Asset Utilization Ratio reached 49.0% in 2022, while the deepest fall reached 25.19% in 2022.
• Jazz Pharmaceuticals' Asset Utilization Ratio stood at 0.34 in 2022, then fell by 1.61% to 0.34 in 2023, then retreated by 1.18% to 0.34 in 2024, then gained by 10.59% to 0.37 in 2025, then grew by 1.78% to 0.38 in 2026.
• Business Quant data shows JAZZ's Asset Utilization Ratio at 0.38 in Q1 2026, 0.37 in Q4 2025, and 0.37 in Q3 2025.